Content about Diabetes mellitus

WHAT IT MEANS AND WHY IT'S IMPORTANT — The results of CVS Caremark’s study, which found that its Pharmacy Advisor program increased medication adherence rates and physician initiation of prescriptions, is important as it further underscores the benefits of the program, and those benefits are bound to becomes even greater as the retailer gears up for the next generation of the clinical program.

SAN DIEGO — A special focus on its diabetes franchise will define Amylin Pharmaceuticals' corporate strategy, the company's chief executive said at a recent conference sponsored by J.P. Morgan.

ORLANDO, Fla. — Winn-Dixie on Tuesday joined the Diabetes Prevention and Control Alliance, an initiative aimed at tipping the scales against the epidemic of diabetes, prediabetes and obesity by expanding access to community-based programs that use evidence-based approaches to help prevent and control diabetes.

PITTSBURGH — Generic drug maker Mylan is challenging the patent on a drug used to treat diabetes, the company said Monday.

Mylan said that it was sued by Takeda Pharmaceutical, Watson Pharmaceuticals and Andrx Labs in the U.S. District Court for the Southern District of New York in response to Mylan's filing a regulatory approval application with the Food and Drug Administration for a generic version of Actoplus Met XR (pioglitazone hydrochloride and metformin hydrochloride) extended-release tablets in the 15-mg/1,000-mg and 30-mg/1,000-mg strengths.

ALEXANDRIA, Va. — Many patients that are at risk of Type 2 diabetes don't believe they require lifestyle counseling to help them curb their chance of developing the disease, according to new research published in the journal Diabetes Care.

WASHINGTON — A joint program of the National Institutes of Health and the Centers for Disease Control and Prevention has a new chairman.

John Buse of the University of North Carolina at Chapel Hill School of Medicine was appointed chair of the National Diabetes Education Program for a two-year term on Jan. 1. Buse succeeds Martha Funnell, who is a researcher at the University of Michigan Medical School, Ann Arbor, as well as co-director of the Behavioral, Clinical, and Health Systems Intervention Research Core at the Michigan Diabetes Research and Training Center.

The market for meal replacement ready-to-drink shakes is expanding beyond the need for a shake-shake-sensible-meal diet plan, or the need for a protein booster, with a number of niche marketing opportunities.


NEW YORK — Mothers that have low socioeconomic status and develop gestational diabetes during pregnancy are more likely to bear children that are diagnosed with attention deficit hyperactivity disorder, according to a new study published in the Archives of Pediatrics & Adolescent Medicine.

WORCESTER, Mass. — Researchers at the University of Massachusetts Medical School said a diabetes prevention program they created was able to reduce prediabetes indicators among Latinos who were at risk of developing the disease.

NEW YORK — Israeli drug maker Teva Pharmaceutical Industries is developing a protein that could offer a new way to treat Type 1 diabetes, according to published reports.

Type 1 diabetes is an autoimmune disorder in which the immune system attacks the pancreas's beta cells, but the drug, DiaPep277, stops that from happening, according to Bloomberg.

HAMILTON, Ontario — Short bursts of exercise appear to lower blood sugar in people with Type 2 diabetes, researchers at Canada's McMaster University have found.

DUBAI — A study conducted by Bristol-Myers Squibb and AstraZeneca found that adding an investigational compound to an existing Type 2 diabetes treatment may help reduce blood-glucose levels among patients.